Laurel Wealth Advisors (North Carolina)’s Teva Pharmaceuticals TEVA Stock Holding History

Laurel Wealth Advisors (North Carolina)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$569K	Buy
2025 Q1	$8.75K	Hold
2024 Q4	$12.5K	Hold
2024 Q3	$10.3K	Buy
2024 Q2	$3.83K	Buy